This conference has been rescheduled to 2021
As you are aware, coronavirus is having a global impact and the World Health Organization and the Centers for Disease Control have instituted recommendations that include social distancing and cancelling conferences and large gatherings. Since safety of our attendees is always GRC's highest priority, the GRC Board of Trustees has decided to withdraw this conference from the 2020 schedule and reschedule it to 2021. The 2021 conference will take place April 25-30, 2021 at the Renaissance Tuscany Il Ciocco, Italy. This decision was made out of an abundance of caution and to alleviate the concerns of our conference communities that are scheduled to meet in this timeframe.
The 2020 Gordon Conference on Ligand Recognition and Molecular Gating will address the molecular mechanisms and physiological roles of three important classes of membrane proteins: ion channels, transporters and G-protein coupled receptors. These proteins play key roles in physiology, their malfunction is implicated in a large number of neuromuscular, endocrine, cardiac and metabolic disorders and therefore are major pharmacological targets. This year, the Conference will integrate the cryoEM-fueled explosion in understanding the structural bases of function of these proteins, with an expanded elucidation of their roles in human physiology and their exploitation as drug targets.
The Conference makes an explicit effort to encourage young scientists to present their work and to discuss with more established investigators. All participants are asked to submit abstracts and bring posters, from which we will select additional speakers for short talks. A Gordon Research Seminar (GRS) will precede the GRC and will provide young scientists with expanded opportunities to present their work and to meet experienced scientists in an informal setting. We strongly encourage graduate students and post-doctoral fellows to apply to the GRS and to stay for the GRC. We would also like to invite scientists from industry, as the membrane proteins discussed at this GRC/GRS are major drug targets. We strongly encourage minorities and people with disabilities to apply. We are trying to secure funding to support in part those with financial constraints.